|
1
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. Jama. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanif R, Qiao L, Shiff SJ and Rigas B:
Curcumin, a natural plant phenolic food additive, inhibits cell
proliferation and induces cell cycle changes in colon
adenocarcinoma cell lines by a prostaglandin-independent pathway. J
Lab Clin Med. 130:576–584. 1997. View Article : Google Scholar
|
|
3
|
Hong J, Lu H, Meng X, Ryu JH, Hara Y and
Yang CS: Stability, cellular uptake, biotransformation, and efflux
of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human
colon adenocarcinoma cells. Cancer Res. 62:7241–7246.
2002.PubMed/NCBI
|
|
4
|
Tsukuda K, Tanino M, Soga H, Shimizu N and
Shimizu K: A novel activating mutation of the K-ras gene in human
primary colon adenocarcinoma. Biochem Biophys Res Commun.
278:653–658. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji W, Sun B and Su C: Targeting microRNAs
in cancer gene therapy. Genes (Basel). 8. pii; pp. E212017,
View Article : Google Scholar
|
|
9
|
Sachdeva M and Mo YY: miR-145-mediated
suppression of cell growth, invasion and metastasis. Am J Transl
Res. 2:170–180. 2010.PubMed/NCBI
|
|
10
|
Fei B and Wu H: MiR-378 inhibits
progression of human gastric cancer MGC-803 cells by targeting MAPK
in vitro. Oncol Res. 20:557–564. 2013. View Article : Google Scholar
|
|
11
|
Steibel JP, Poletto R, Coussens PM and
Rosa GJ: A powerful and flexible linear mixed model framework for
the analysis of relative quantification RT-PCR data. Genomics.
94:146–152. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vidya Priyadarsini R, Senthil Murugan R,
Maitreyi S, Ramalingam K, Karunagaran D and Nagini S: The flavonoid
quercetin induces cell cycle arrest and mitochondria-mediated
apoptosis in human cervical cancer (HeLa) cells through p53
induction and NF-κB inhibition. Eur J Pharmacol. 649:84–91. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kasibhatla S, Amarante-Mendes GP, Finucane
D, Brunner T, Bossy-Wetzel E and Green DR: Acridine orange/ethidium
bromide (AO/EB) staining to detect apoptosis. CSH Protoc.
2006:pii:pdb-rot44932006.
|
|
14
|
Wang Y, Zhao W and Fu Q: miR-335
suppresses migration and invasion by targeting ROCK1 in
osteosarcoma cells. Mol Cell Biochem. 384:105–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gotham SM, Fryer PJ and Paterson WR: The
measurement of insoluble proteins using a modified Bradford assay.
Anal Biochem. 173:353–358. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fhaner CJ, Liu S, Ji H, Simpson RJ and
Reid GE: Comprehensive lipidome profiling of isogenic primary and
metastatic colon adenocarcinoma cell lines. Anal Chem.
84:8917–8926. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T,
Chen Z and Liu L: ROR functions as a ceRNA to regulate Nanog
expression by sponging miR-145 and predicts poor prognosis in
pancreatic cancer. Oncotarget. 7:1608–1618. 2016.
|
|
20
|
Yin R, Zhang S, Wu Y, Fan X, Jiang F,
Zhang Z, Feng D, Guo X and Xu L: microRNA-145 suppresses lung
adenocarcinoma-initiating cell proliferation by targeting OCT4.
Oncol Rep. 25:1747–1754. 2011.PubMed/NCBI
|
|
21
|
Arndt GM, Dossey L, Cullen LM, Lai A,
Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang JY and Richardson BC: The MAPK
signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li XW, Tuergan M and Abulizi G: Expression
of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on
epithelial-mesenchymal transition, invasion and metastasis. Asian
Pac J Trop Med. 8:937–943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lwin WW, Park K, Wauson M, Gao Q, Finn PW,
Perkins D and Khanna A: Systems biology approach to transplant
tolerance: Proof of concept experiments using RNA interference
(RNAi) to knock down hub genes in Jurkat and HeLa cells in vitro. J
Surg Res. 176:e41–e462012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li XW, Tuergan M and Abulizi G: Expression
of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on
epithelial mesenchymal transition, invasion and metastasis. Asian
Pac J Trop Med. 8:937–943. 2015. View Article : Google Scholar : PubMed/NCBI
|
